Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
about
Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disordersThe environment within: exploring the role of the gut microbiome in health and diseaseTherapeutic faecal microbiota transplantation: current status and future developmentsThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsBugging inflammation: role of the gut microbiotaGenetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and FutureGut microbiota role in irritable bowel syndrome: New therapeutic strategiesCurrent stage in inflammatory bowel disease: What is next?Management of ulcerative colitisHuman microbiome: From the bathroom to the bedsideFecal microbiota transplantation: indications, methods, evidence, and future directionsUse of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune systemUpdate on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and OutlookIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseaseProbiotic use in horses - what is the evidence for their clinical efficacy?The Microbiome and Sustainable Healthcare.Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel diseaseNew treatments for ulcerative colitis: do we have pediatric data?Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics.The microbiome in inflammatory bowel disease: current status and the future ahead.Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.The microbiota in inflammatory bowel disease: current and therapeutic insightsMultiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass.Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?From stool transplants to next-generation microbiota therapeuticsEnteric microbiota leads to new therapeutic strategies for ulcerative colitis.Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.Fecal microbiota transplantation broadening its application beyond intestinal disorders.Guidance on preparing an investigational new drug application for fecal microbiota transplantation studiesManipulating the gut microbiota to maintain health and treat disease.Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics.Why is initial bacterial colonization of the intestine important to infants' and children's health?Relationship between gut microbiota and development of T cell associated disease.Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results.Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy.Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitementThe gut microbiota and inflammatory bowel disease.
P2860
Q24599041-2C14F5BD-79AE-4D6B-9E41-C5E002A7441FQ24628275-7B1FF124-E344-4C10-9D6A-6FD565D25320Q24629302-F84BDCCB-DDDC-48B5-914D-50435AC7D022Q26745700-D9BAFB97-1519-48F0-8D0C-54BD3A0DAA33Q26748440-A6590627-62E9-4E28-86BC-1110853F304BQ26765893-8BE67955-B1BB-431A-AB91-E5375E1B5261Q26768550-06354EDE-E075-4E20-AB2D-44D1E5F54185Q26777429-F9C5B208-1845-4548-92A6-B20173C1C526Q26778250-F5C81C31-5E62-4FE5-94BF-623158F970FBQ26795386-2092B34A-A359-4964-B40D-DDD4160AF920Q26830134-3A810C57-ED09-44B3-AE71-CC76D403D998Q26853628-8CCC6A8F-D7E2-4536-9714-C75E78099921Q26995945-C747DD76-CA06-4C21-8FF4-056D5C81728AQ27003192-67E9CD5C-4664-410A-A45A-113D4FC38DCEQ27021831-CEF6B87B-0BB3-4797-A914-2D91B4D45D94Q28088606-152CDAEF-F8C6-4AFF-A203-2327B978EB0DQ28254207-64A0A45D-5532-4468-B887-770D97FC35D1Q31076366-68BA858E-3F25-44DF-8AE5-1A3C5BF15300Q33640440-01EEA2F8-0837-42DC-B093-6E4CE3011774Q33664898-B2018D26-B6EF-4B57-AF6A-424E20373DA2Q33686153-879D942C-FC2F-4E3A-9F38-023CCE44C125Q33717111-10ED8753-94CE-49C8-B65B-1D9ACC479C7DQ33806817-08F85D52-E785-4CE8-A494-0904BAB686B3Q33881185-98FB0041-9EBE-455B-B0EC-90040E7C0B92Q34042017-07EC5456-CB52-4BDA-825A-26473065B755Q34407175-9AABC448-680B-4E21-BBFD-49FB09355069Q34458414-C725BC8A-4126-417F-A5D7-EC1D2C3F54C1Q34499080-E0FDBC6A-6C4E-4ABC-B9FB-19CAF99FCB24Q34589700-CEAF4EE5-C9C5-4F5E-971D-4D8580B583E9Q34667433-9A73B1C1-1DF1-4609-A3E1-45A621F4D025Q35012615-5EEAABDD-7BB7-4B0E-A9D7-CFB8FEFF4696Q35044588-66630B94-6668-4C7B-B607-0A190208A538Q35057680-B48A2C35-C568-4F88-AE6D-101B69056E12Q35122316-1F974E05-603C-42AF-B6A1-B7A75F1B5EDEQ35134829-8587D5F6-52BC-49ED-8EE1-B5B6CC749E70Q35195891-C0EE957C-EB22-4A18-BE33-04738AB8265DQ35234409-6627BD1E-C9DD-4F07-A16B-C061EF0EAECEQ35260563-CD254080-DE4C-4263-9458-9836F28B1CE5Q35361200-4A27110E-DBD7-4BB2-9E67-1998650152CFQ35446516-CD309822-5A5E-40B6-A68A-CFFB55E1D456
P2860
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@ast
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@en
type
label
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@ast
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@en
prefLabel
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@ast
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@en
P2093
P1476
Safety, tolerability, and clin ...... dults with ulcerative colitis.
@en
P2093
Angela Pham
Deborah Cloney
Harold Conrad
Sachin Kunde
Sarah Bonczyk
Subra Kugathasan
Teri Crumb
P304
P356
10.1097/MPG.0B013E318292FA0D
P407
P577
2013-06-01T00:00:00Z